Global Next Generation Probiotics Market

Next Generation Probiotics Comprehensive Study by Application (Autoimmune Diseases, Glucose Management, Inflammatory Bowel Disease, Others), Category (Akkermansia Muciniphila, Faecalibacterium Prausnitzii, Bacteroides Fragilis, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2028

Next Generation Probiotics Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Next generation probiotics is a broad term that refers to a new generation of probiotic products that are designed to provide enhanced benefits for human health. Probiotics are live microorganisms that, when consumed in adequate amounts, offer health benefits to the host. The NGPs enhance gastrointestinal immunity, maintain intestinal barrier integrity, produce beneficial metabolites, act against pathogens, and improve immunotherapy efficacy.

Highlights from Next Generation Probiotics Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The key Players profiled in the report are Pendulum Therapeutics Inc. (United States), Winclove Probiotics B.V. (Netherlands), Metabogen AB (Sweden), Exeliom Biosciences (France), TargEDys (France), Chr. Hansen A/S (Denmark), YSOPIA Bioscience (France), BioGaia (Sweden), A-Mansia Biotech (Belgium) and Evolve Biosystems (United States).

Geographic Breakdown and Segment Analysis
The Global Next Generation Probiotics market presents a comprehensive analysis of the Next Generation Probiotics market by end-user/application (Autoimmune Diseases, Glucose Management, Inflammatory Bowel Disease and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Next Generation Probiotics industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Next Generation Probiotics market

Analyst at AMA have segmented the market study of Global Next Generation Probiotics market by Type, Application and Region.

Influencing Trend:
Increasing Use of Probiotics as Potential Biotherapeutic Agents

Market Growth Drivers:
Increasing Prevalence of Digestive Disorders and Rise in Awareness of the Importance of Gut Health among People

Challenges:
Highly Competitive With Numerous Players

Restraints:
Stringent Rules and Regulations for Product Approval

Opportunities:
Collaboration with Healthcare Professionals Such As Doctors, Nutritionists, and Dieticians, Presents an Opportunity for Market Growth

Market Developments Activities:
In September 2022, TargEDys and Inoliva, have signed an agreement for the marketing and distribution of Satylia, a food supplement based on the next-generation probiotic Hafnia alvei HA4597, to the Turkish market
In July 2022, BioGaia launched a probiotic product to support children’s respiratory health, which aims to strengthen the immune system and support children’s upper respiratory health and In December 2020, Netherlands-based Winclove Probiotics is developing Novobiome, a new platform to bring human-derived, next-generation probiotics (NGPs) to the European market

Regulatory Insights:
In the United States, the FDA regulates probiotics as dietary supplements. The FDA's Center for Food Safety and Applied Nutrition (CFSAN) oversees the safety and labeling of dietary supplements, including probiotic products. Manufacturers of probiotics are required to comply with FDA regulations, including good manufacturing practices (GMPs) and labeling requirements.

Major players have adopted various strategies such as expansions, investments, new product launches, and collaborations as their preferred strategies. Apart from this, the players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Key Target Audience
Manufacturers, Suppliers, and Distributors, Potential Investors, Government Institutes, Regulatory Authorities, Research and Development Institutes, Market Research & Consulting Firms and Others

Report Objectives / Segmentation Covered

By Application
  • Autoimmune Diseases
  • Glucose Management
  • Inflammatory Bowel Disease
  • Others
By Category
  • Akkermansia Muciniphila
  • Faecalibacterium Prausnitzii
  • Bacteroides Fragilis
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Digestive Disorders
      • 3.2.2. Rise in Awareness of the Importance of Gut Health among People
    • 3.3. Market Challenges
      • 3.3.1. Highly Competitive With Numerous Players
    • 3.4. Market Trends
      • 3.4.1. Increasing Use of Probiotics as Potential Biotherapeutic Agents
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Next Generation Probiotics, by Application, Category, Distribution Channel and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Next Generation Probiotics (Value)
      • 5.2.1. Global Next Generation Probiotics by: Application (Value)
        • 5.2.1.1. Autoimmune Diseases
        • 5.2.1.2. Glucose Management
        • 5.2.1.3. Inflammatory Bowel Disease
        • 5.2.1.4. Others
      • 5.2.2. Global Next Generation Probiotics by: Category (Value)
        • 5.2.2.1. Akkermansia Muciniphila
        • 5.2.2.2. Faecalibacterium Prausnitzii
        • 5.2.2.3. Bacteroides Fragilis
        • 5.2.2.4. Others
      • 5.2.3. Global Next Generation Probiotics by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Next Generation Probiotics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Next Generation Probiotics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pendulum Therapeutics Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Winclove Probiotics B.V. (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Metabogen AB (Sweden)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Exeliom Biosciences (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. TargEDys (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Chr. Hansen A/S (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. YSOPIA Bioscience (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioGaia (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. A-Mansia Biotech (Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Evolve Biosystems (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Next Generation Probiotics Sale, by Application, Category, Distribution Channel and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Next Generation Probiotics (Value)
      • 7.2.1. Global Next Generation Probiotics by: Application (Value)
        • 7.2.1.1. Autoimmune Diseases
        • 7.2.1.2. Glucose Management
        • 7.2.1.3. Inflammatory Bowel Disease
        • 7.2.1.4. Others
      • 7.2.2. Global Next Generation Probiotics by: Category (Value)
        • 7.2.2.1. Akkermansia Muciniphila
        • 7.2.2.2. Faecalibacterium Prausnitzii
        • 7.2.2.3. Bacteroides Fragilis
        • 7.2.2.4. Others
      • 7.2.3. Global Next Generation Probiotics by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Next Generation Probiotics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Next Generation Probiotics: by Application(USD Million)
  • Table 2. Next Generation Probiotics Autoimmune Diseases , by Region USD Million (2017-2022)
  • Table 3. Next Generation Probiotics Glucose Management , by Region USD Million (2017-2022)
  • Table 4. Next Generation Probiotics Inflammatory Bowel Disease , by Region USD Million (2017-2022)
  • Table 5. Next Generation Probiotics Others , by Region USD Million (2017-2022)
  • Table 6. Next Generation Probiotics: by Category(USD Million)
  • Table 7. Next Generation Probiotics Akkermansia Muciniphila , by Region USD Million (2017-2022)
  • Table 8. Next Generation Probiotics Faecalibacterium Prausnitzii , by Region USD Million (2017-2022)
  • Table 9. Next Generation Probiotics Bacteroides Fragilis , by Region USD Million (2017-2022)
  • Table 10. Next Generation Probiotics Others , by Region USD Million (2017-2022)
  • Table 11. Next Generation Probiotics: by Distribution Channel(USD Million)
  • Table 12. Next Generation Probiotics Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 13. Next Generation Probiotics Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 14. Next Generation Probiotics Online Pharmacies , by Region USD Million (2017-2022)
  • Table 15. South America Next Generation Probiotics, by Country USD Million (2017-2022)
  • Table 16. South America Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 17. South America Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 18. South America Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 19. Brazil Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 20. Brazil Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 21. Brazil Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 22. Argentina Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 23. Argentina Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 24. Argentina Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 25. Rest of South America Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 26. Rest of South America Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 27. Rest of South America Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 28. Asia Pacific Next Generation Probiotics, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 30. Asia Pacific Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 31. Asia Pacific Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 32. China Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 33. China Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 34. China Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 35. Japan Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 36. Japan Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 37. Japan Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 38. India Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 39. India Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 40. India Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 41. South Korea Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 42. South Korea Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 43. South Korea Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 44. Taiwan Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 45. Taiwan Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 46. Taiwan Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 47. Australia Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 48. Australia Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 49. Australia Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 53. Europe Next Generation Probiotics, by Country USD Million (2017-2022)
  • Table 54. Europe Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 55. Europe Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 56. Europe Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 57. Germany Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 58. Germany Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 59. Germany Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 60. France Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 61. France Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 62. France Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 63. Italy Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 64. Italy Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 65. Italy Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 66. United Kingdom Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 67. United Kingdom Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 68. United Kingdom Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 69. Netherlands Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 70. Netherlands Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 71. Netherlands Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 72. Rest of Europe Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 73. Rest of Europe Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 74. Rest of Europe Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 75. MEA Next Generation Probiotics, by Country USD Million (2017-2022)
  • Table 76. MEA Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 77. MEA Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 78. MEA Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 79. Middle East Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 80. Middle East Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 81. Middle East Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 82. Africa Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 83. Africa Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 84. Africa Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 85. North America Next Generation Probiotics, by Country USD Million (2017-2022)
  • Table 86. North America Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 87. North America Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 88. North America Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 89. United States Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 90. United States Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 91. United States Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 92. Canada Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 93. Canada Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 94. Canada Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 95. Mexico Next Generation Probiotics, by Application USD Million (2017-2022)
  • Table 96. Mexico Next Generation Probiotics, by Category USD Million (2017-2022)
  • Table 97. Mexico Next Generation Probiotics, by Distribution Channel USD Million (2017-2022)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Next Generation Probiotics: by Application(USD Million)
  • Table 109. Next Generation Probiotics Autoimmune Diseases , by Region USD Million (2023-2028)
  • Table 110. Next Generation Probiotics Glucose Management , by Region USD Million (2023-2028)
  • Table 111. Next Generation Probiotics Inflammatory Bowel Disease , by Region USD Million (2023-2028)
  • Table 112. Next Generation Probiotics Others , by Region USD Million (2023-2028)
  • Table 113. Next Generation Probiotics: by Category(USD Million)
  • Table 114. Next Generation Probiotics Akkermansia Muciniphila , by Region USD Million (2023-2028)
  • Table 115. Next Generation Probiotics Faecalibacterium Prausnitzii , by Region USD Million (2023-2028)
  • Table 116. Next Generation Probiotics Bacteroides Fragilis , by Region USD Million (2023-2028)
  • Table 117. Next Generation Probiotics Others , by Region USD Million (2023-2028)
  • Table 118. Next Generation Probiotics: by Distribution Channel(USD Million)
  • Table 119. Next Generation Probiotics Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 120. Next Generation Probiotics Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 121. Next Generation Probiotics Online Pharmacies , by Region USD Million (2023-2028)
  • Table 122. South America Next Generation Probiotics, by Country USD Million (2023-2028)
  • Table 123. South America Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 124. South America Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 125. South America Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 126. Brazil Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 127. Brazil Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 128. Brazil Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 129. Argentina Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 130. Argentina Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 131. Argentina Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 132. Rest of South America Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 133. Rest of South America Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 134. Rest of South America Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 135. Asia Pacific Next Generation Probiotics, by Country USD Million (2023-2028)
  • Table 136. Asia Pacific Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 137. Asia Pacific Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 138. Asia Pacific Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 139. China Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 140. China Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 141. China Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 142. Japan Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 143. Japan Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 144. Japan Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 145. India Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 146. India Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 147. India Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 148. South Korea Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 149. South Korea Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 150. South Korea Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 151. Taiwan Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 152. Taiwan Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 153. Taiwan Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 154. Australia Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 155. Australia Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 156. Australia Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 160. Europe Next Generation Probiotics, by Country USD Million (2023-2028)
  • Table 161. Europe Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 162. Europe Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 163. Europe Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 164. Germany Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 165. Germany Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 166. Germany Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 167. France Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 168. France Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 169. France Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 170. Italy Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 171. Italy Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 172. Italy Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 173. United Kingdom Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 174. United Kingdom Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 175. United Kingdom Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 176. Netherlands Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 177. Netherlands Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 178. Netherlands Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 179. Rest of Europe Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 180. Rest of Europe Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 181. Rest of Europe Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 182. MEA Next Generation Probiotics, by Country USD Million (2023-2028)
  • Table 183. MEA Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 184. MEA Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 185. MEA Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 186. Middle East Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 187. Middle East Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 188. Middle East Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 189. Africa Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 190. Africa Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 191. Africa Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 192. North America Next Generation Probiotics, by Country USD Million (2023-2028)
  • Table 193. North America Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 194. North America Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 195. North America Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 196. United States Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 197. United States Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 198. United States Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 199. Canada Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 200. Canada Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 201. Canada Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 202. Mexico Next Generation Probiotics, by Application USD Million (2023-2028)
  • Table 203. Mexico Next Generation Probiotics, by Category USD Million (2023-2028)
  • Table 204. Mexico Next Generation Probiotics, by Distribution Channel USD Million (2023-2028)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Next Generation Probiotics: by Application USD Million (2017-2022)
  • Figure 5. Global Next Generation Probiotics: by Category USD Million (2017-2022)
  • Figure 6. Global Next Generation Probiotics: by Distribution Channel USD Million (2017-2022)
  • Figure 7. South America Next Generation Probiotics Share (%), by Country
  • Figure 8. Asia Pacific Next Generation Probiotics Share (%), by Country
  • Figure 9. Europe Next Generation Probiotics Share (%), by Country
  • Figure 10. MEA Next Generation Probiotics Share (%), by Country
  • Figure 11. North America Next Generation Probiotics Share (%), by Country
  • Figure 12. Global Next Generation Probiotics share by Players 2022 (%)
  • Figure 13. Global Next Generation Probiotics share by Players (Top 3) 2022(%)
  • Figure 14. Global Next Generation Probiotics share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Pendulum Therapeutics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Pendulum Therapeutics Inc. (United States) Revenue: by Geography 2022
  • Figure 18. Winclove Probiotics B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 19. Winclove Probiotics B.V. (Netherlands) Revenue: by Geography 2022
  • Figure 20. Metabogen AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. Metabogen AB (Sweden) Revenue: by Geography 2022
  • Figure 22. Exeliom Biosciences (France) Revenue, Net Income and Gross profit
  • Figure 23. Exeliom Biosciences (France) Revenue: by Geography 2022
  • Figure 24. TargEDys (France) Revenue, Net Income and Gross profit
  • Figure 25. TargEDys (France) Revenue: by Geography 2022
  • Figure 26. Chr. Hansen A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 27. Chr. Hansen A/S (Denmark) Revenue: by Geography 2022
  • Figure 28. YSOPIA Bioscience (France) Revenue, Net Income and Gross profit
  • Figure 29. YSOPIA Bioscience (France) Revenue: by Geography 2022
  • Figure 30. BioGaia (Sweden) Revenue, Net Income and Gross profit
  • Figure 31. BioGaia (Sweden) Revenue: by Geography 2022
  • Figure 32. A-Mansia Biotech (Belgium) Revenue, Net Income and Gross profit
  • Figure 33. A-Mansia Biotech (Belgium) Revenue: by Geography 2022
  • Figure 34. Evolve Biosystems (United States) Revenue, Net Income and Gross profit
  • Figure 35. Evolve Biosystems (United States) Revenue: by Geography 2022
  • Figure 36. Global Next Generation Probiotics: by Application USD Million (2023-2028)
  • Figure 37. Global Next Generation Probiotics: by Category USD Million (2023-2028)
  • Figure 38. Global Next Generation Probiotics: by Distribution Channel USD Million (2023-2028)
  • Figure 39. South America Next Generation Probiotics Share (%), by Country
  • Figure 40. Asia Pacific Next Generation Probiotics Share (%), by Country
  • Figure 41. Europe Next Generation Probiotics Share (%), by Country
  • Figure 42. MEA Next Generation Probiotics Share (%), by Country
  • Figure 43. North America Next Generation Probiotics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Pendulum Therapeutics Inc. (United States)
  • Winclove Probiotics B.V. (Netherlands)
  • Metabogen AB (Sweden)
  • Exeliom Biosciences (France)
  • TargEDys (France)
  • Chr. Hansen A/S (Denmark)
  • YSOPIA Bioscience (France)
  • BioGaia (Sweden)
  • A-Mansia Biotech (Belgium)
  • Evolve Biosystems (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 223 Pages 83 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Next Generation Probiotics Market Quantitative research analysis
Global Next Generation Probiotics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2028
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Highly Competitive With Numerous Players

Know More About Global Next Generation Probiotics Market Report?

Have a Query? Click Here

Other Related Reports

Medical Manuka Honey Comprehensive Study by Application (Healthcare, Skin Care Industry, Others), Distribution Channel (Online, Offline), Category Type (K-Factor, K-Factor 12, K-Factor 16, K-Factor 2...
$ 3800
Digital Payment in Healthcare Comprehensive Study by Type (On-Premise, Cloud), By Enterprise size (Small size, Medium size, Large size), By Component (Solution, Service, Intelligence), Payment Mode...
$ 3800
Cell Therapy Market Comprehensive Study by Application (Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds, Other), Type (Autologous, Allogeneic), End User (Hospitals, Homecare, S...
$ 3800
Big Data in the Healthcare & Pharmaceutical Industry Comprehensive Study by Application (Financial Analytics, Clinical Data Analytics, Operational Analytics, Population Health Analytics), Deployment ...
$ 3800